Why the investment that never fits a budget category keeps losing, and what to put in front of finance instead Budgets run annually. Architecture consequences run five to seven years. Every R&D leader in medtech understands this, and almost no planning process accounts for it. A platform decision made this quarter will shape what your […]

Three numbers from the latest Medtech Big 100 and what they should change about your FY27 planning Three numbers from Medical Design & Outsourcing’s most recent Medtech Big 100 analysis are worth putting side by side. Aggregate revenue across the world’s largest device companies hit a record $486.7 billion, up nearly 3 percent. R&D spending […]

Where the Money Actually Goes Why your R&D spend, not your strategy deck, tells the truth about your portfolio The decisions you make in R&D today will not be visible for two years. That is the uncomfortable math of this job. What you choose to work on right now is what you and your team […]

The Only Metric That Actually Predicts Team Performance You Can’t Mandate High Performance. You Have to Build It. Early in my career, I was asked to run a team performance workshop I did not want to do. My R&D team was missing deadlines. Progress was happening, but communication was not. My executive leader pushed me […]

Insights from the MassMEDIC Webinar with Bryan Gilpin and Terri Kapur Every medtech leader I talk to is under pressure to move faster. That pressure is real, and it is not going away. But across the industry, we keep seeing the same thing play out: the harder organizations push for speed, the more they can […]

New product development processes that are overly siloed are stifling medtech innovation. Here’s why and the steps you can take to get engineering, clinical, regulatory, marketing, and manufacturing all working in parallel from day one.